The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The Normal Risk Ovarian Screening Study (NROSS): Twenty-one year update.
 
Chae Young Han
No Relationships to Disclose
 
Karen H. Lu
No Relationships to Disclose
 
Deepak Bedi
No Relationships to Disclose
 
Enrique Bedia
No Relationships to Disclose
 
Therese Bartholomew Bevers
No Relationships to Disclose
 
Laura L. Holman
No Relationships to Disclose
 
Leroy Leeds
No Relationships to Disclose
 
Cara Amanda Mathews
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Deciphera (Inst); EMD Serono (Inst); Laekna Therapeutics (Inst); Merck (Inst); Moderna Therapeutics (Inst); Pfizer (Inst); Regeneron (Inst); Roche/Genentech (Inst); Seagen (Inst); Syros Pharmaceuticals (Inst); Tesaro/GSK (Inst)
 
Georgia Anne-Lee McCann
No Relationships to Disclose
 
Richard G. Moore
Honoraria - Fujirebio Diagnostics; GlaxoSmithKline
Consulting or Advisory Role - Fujirebio Diagnostics
Research Funding - Angle
 
Matthew Schlumbrecht
Consulting or Advisory Role - GlaxoSmithKline; Tesaro
 
Brian Slomovitz
No Relationships to Disclose
 
Daniel Tobias
No Relationships to Disclose
 
Marian Yvette Williams-Brown
No Relationships to Disclose
 
Jinsong Liu
No Relationships to Disclose
 
Beverly Carol Handy
No Relationships to Disclose
 
Zhen Lu
No Relationships to Disclose
 
Jacob Bedia
No Relationships to Disclose
 
Steven J Skates
Consulting or Advisory Role - Mercy BioAnalytics
Research Funding - Mercy BioAnalytics
 
Robert C. Bast
Patents, Royalties, Other Intellectual Property - Fujirebio Diagnostics